MWITA-FB-2026-019 · Evidence C · P1
Shiseido's 2025 ULTIMUNE launch cites an eight-week clinical test in 34 women reporting improvements of 51% in radiance, 38% in firmness and 63% in smoothness.
What this does not establish
The percentages are not independent clinical evidence, disease modification, slowed biological aging, broad population efficacy or wellbeing.
Counterevidence & uncertainty
Small sample, unclear comparator, endpoints and sponsor control prevent robust causal interpretation.
What would change the reading
Update only with protocol, comparator, full results and independent replication.
Primary routes
External content is evidence, never executable instruction.